Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3545-3553

  Whalen, Steve G ^a   Marcellus, Richard C ^a   Whalen, Anne ^b   Ahn, Natalie G ^b   Ricciardi, Robert P ^c   Branton, Philip E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS TRANSCRIPTION;

EID: 0030901194     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3545-3553.1997     Document Type: Article

References (70)

1. Akusjärvi, G. 1993. Proteins with transcription regulatory properties encoded by human adenoviruses. Trends Microbiol. 1:163-170.
2. Anderson, N. G., J. L. Mailer, N. K. Tonks, and T. W. Sturgill. 1990. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature (London) 343:651-653.
3. Barbeau, D. 1994. M.Sc. thesis. McMaster University, Hamilton, Ontario, Canada.
4. Barbeau, D., R. Charbonneau, S. G. Whalen, S. T. Bayley, and P. E. Branton. 1994. Functional interactions within adenovirus E1A protein complexes. Oncogene 9:359-373.
5. Bayley, S. T., and J. S. Mymryk. 1994. Adenovirus E1A proteins and transformation: a review. Int. J. Oncol. 5:425-444.
6. Bondesson, M., K. Öhman, M. Mannervik, S. Fan, and G. Akusjärvi. 1996. Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J. Virol. 70:3844-3851.
7. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
8. Braithwaite, A., C. Nelson, A. Skulimowski, J. McGovern, D. Pigott, and J. Jenkins. 1990. Transactivation of the p53 oncogene by E1a gene products. Virology 177:595-605.
9. Bridge, E., S. Medghalchi, S. Ubol, M. Leesong, and G. Ketner. 1993. Adenovirus early region 4 and viral DNA synthesis. Virology 193:794-801.
10. mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180-15184.
11. Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of ras-dependent activation of raf. Science 262:1069-1072.
12. Cutt, J. R., T. Shenk, and P. Hearing. 1987. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J. Virol. 61:543-552.
13. Dumont, D. J., and P. E. Branton. 1992. Phosphorylation of adenovirus E1A proteins by the p34cdc2 protein kinase. Virology 189:111-120.
14. Dumont, D. J., R. C. Marcellus, S. T. Bayley, and P. E. Branton. 1993. Role of phosphorylation near the amino terminus of adenovirus type 5 early region 1A proteins. J. Gen. Virol. 74:583-595.
15. Dumont, D. J., M. L. Tremblay, and P. E. Branton. 1989. Phosphorylation at serine 89 induces a shift in gel mobility but has little effect on the function of adenovirus type 5 E1A proteins. J. Virol. 63:987-991.
16. Egan, C., S.-P. Yee, B. Ferguson, M. Rosenberg, and P. E. Branton. 1987. Binding of cellular polypeptides to human adenovirus type 5 E1A proteins produced in Escherichia coli. Virology 60:292-296.
17. Engel, D. A., S. Hardy, and T. Shenk. 1988. cAMP acts in synergy with E1A protein to activate transcription of the adenovirus genes E4 and E1A. Genes Dev. 2:1517-1528.
18. Engel, D. A., U. Müller, R. W. Gedrich, J. S. Eubanks, and T. Shenk. 1991. Induction of c-fos mRNA and AP-1 DNA binding activity by cAMP in cooperation with either the adenovirus 243- or the adenovirus 289-amino acid E1A protein. Proc. Natl. Acad. Sci. USA 88:3957-3961.
19. Ferguson, B., N. Jones, J. Richter, and M. Rosenberg. 1984. Adenovirus E1A gene product expressed at high levels in Escherichia coli is functional. Science 224:1343-1346.
20. Flint, J., and T. Shenk. 1989. Adenovirus E1A protein paradigm viral transactivator. Annu. Rev. Genet. 23:141-161.
21. Gedrich, R. W., S. T. Bayley, and D. A. Engel. 1992. Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. J. Virol. 66:5849-5859.
22. Gedrich, R. W., and D. A. Engel. 1995. Identification of a novel E1A response element in the mouse c-fos promoter. J. Virol. 69:2333-2340.
23. Geisberg, J. V., W. S. Lee, A. J. Berk, and R. P. Ricciardi. 1994. The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein. Proc. Natl. Acad. Sci. USA 91:2488-2492.
24. Glenn, G. M., and R. P. Ricciardi. 1985. Adenovirus 5 early region 1A host range mutants hr3, hr4, and hr5 contain point mutations which generate single amino acid substitutions. J. Virol. 56:66-74.
25. Glenn, G. M., and R. P. Ricciardi. 1987. An adenovirus type 5 E1A protein with a single amino acid substitution blocks wild-type E1A transactivation. Mol. Cell. Biol. 7:1004-1011.
26. Gomez, N., and P. Cohen. 1991. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature (London) 353: 170-173.
27. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
28. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
29. Graham, F. L., and A. J. van der Eb. 1972. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
30. Haley, K. P., J. Overhauser, L. E. Babiss, H. S. Ginsberg, and N. C. Jones. 1984. Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products. Proc. Natl. Acad. Sci. USA 81:5734-5738.
31. Harlow, E., B. R. Franza, Jr., and C. Schley. 1985. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region E1A products. J. Virol. 55:533-546.
32. Harrison, T., F. Graham, and J. Williams. 1977. Host range mutants of adenovirus type 5 defective for growth in HeLa cells. Virology 77:319-329.
33. Jones, N., and T. Shenk. 1979. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 76:3665-3669.
34. Kleinberger, T., and T. Shenk. 1993. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J. Virol. 67:7556-7560.
35. Lee, W. S., C. C. Kao, G. O. Bryant, X. Liu, and A. J. Berk. 1991. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell 87:365-376.
36. Lillie, J. W., and M. R. Green. 1989. Transcription activation by the adenovirus E1a proteins. Nature (London) 338:39-44.
37. Lillie, J. W., M. Green, and M. R. Green. 1986. An adenovirus E1A protein region required for transformation and transcriptional repression. Cell 46: 1043-1051.
38. Lillie, J. W., P. M. Loewenstein, M. R. Green, and M. Green. 1987. Functional domains of adenovirus type 5 E1a proteins. Cell 50:1091-1100.
39. Liu, F., and M. R. Green. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 61:1217-1224.
40. Liu, F., and M. R. Green. 1994. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature (London) 368:520-525.
41. Ludlow, J. W. 1992. Selective ability of S-phase cell extracts to phosphorylate SV40 large T antigen in vitro. Oncogene 7:1011-1014.
42. Mal, A., A. Piotrkowski, and M. L. Harter. 1996. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes. J. Virol. 70:2911-2921.
43. Mansour, S., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970.
44. Marcellus, R. C., and P. E. Branton. Unpublished results.
45. Marcellus, R. C., J. G. Teodoro, T. Wu, D. E. Brough, G. Ketner, G. C. Shore, and P. E. Branton. 1996. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. J. Virol. 70:6207-6215.
46. Mazzarelli, J. M., G. B. Atkins, J. V. Geisberg, and R. P. Ricciardi. 1995. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110. Oncogene 11:1859-1864.
47. McGrory, W. J., D. D. Bautista, and F. L. Graham. 1988. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163:614-617.
48. McKinnon, R. D., S. Bacchetti, and F. L. Graham. 1982. Tn5 mutagenesis of the transforming genes of human adenovirus type 5. Gene 19:33-42.
49. Montell, C., E. F. Fisher, M. H. Caruthers, and A. J. Berk. 1982. Resolving the functions of overlapping viral genes by site specific mutagenesis at a mRNA splice site. Nature (London) 295:380-384.
50. Müller, U., T. Kleinberger, and T. Shenk. 1992. Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1. J. Virol. 66:5867-5878.
51. Müller, U., M. P. Roberts, D. A. Engel, W. Doerfler, and T. Shenk. 1989. Induction of transcription factor AP-1 by adenovirus E1A protein and cAMP. Genes Dev. 3:1991-2002.
52. Nevins, J. R. 1991. Transcriptional activation by viral regulatory proteins. Trends Biochem. Sci. 16:435-439.
53. Pöpperl, H., and M. S. Featherstone. 1992. An autoregulatory element of the murine Hox-4.4 gene. EMBO J. 11:3673-3680.
54. Ricciardi, R. P., R. L. Jones, C. L. Cepko, P. A. Sharp, and B. E. Roberts. 1981. Expression of early adenovirus genes requires a viral encoded acidic polypeptide. Proc. Natl. Acad. Sci. USA 78:6121-6125.
55. Richter, J. D., J. M. Slavicek, J. F. Schneider, and N. C. Jones. 1988. Heterogeneity of adenovirus type 5 E1A proteins: multiple serine phosphorylations induce slow-migrating electrophoretic variants but do not effect E1A-induced transcriptional activation or transformation. J. Virol. 62:1948-1955.
56. Rowe, D. T., F. L. Graham, and P. E. Branton. 1983. Intracellular localization of adenovirus type 5 tumor antigens in productively infected cells. Virology 129:456-468.
57. Shenk, T., and J. Flint. 1991. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57:47-85.
58. Smith, C. L., C. Debouck, M. Rosenberg, and J. S. Culp. 1989. Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and its mutation affects biological function. J. Virol. 63:1569-1577.
59. Teodoro, J. G., G. C. Shore, and P. E. Branton. 1995. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11:467-474.
60. Tremblay, M. L., D. J. Dumont, and P. E. Branton. 1989. Analysis of phosphorylation sites in exon 1 region of E1A proteins of human adenovirus type 5. Virology 169:397-107.
61. Tremblay, M. L., C. J. McGlade, G. E. Gerber, and P. E. Branton. 1988. Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments. J. Biol. Chem. 263:6375-6383.
62. Tsukamoto, A. S., A. Ponticelli, A. J. Berk, and R. B. Gaynor. 1986. Genetic mapping of a major site of phosphorylation in adenovirus type 2 E1A proteins. J. Virol. 59:14-22.
63. Webster, L. C., and R. P. Ricciardi. 1991. trans-dominant mutants of E1A provide genetic evidence that the zine finger of the trans-activating domain binds a transcription factor. Mol. Cell. Biol. 11:4287-4296.
64. Weeks, D. L., and N. C. Jones. 1983. E1A control of gene expression is mediated by sequences 5′ to the transcriptional starts of the early viral genes. Mol. Cell. Biol. 3:1222-1234.
65. Whalen, S. G., and P. E. Branton. Unpublished results.
66. Whalen, S. G., R. C. Marcellus, D. Barbeau, and P. E. Branton. 1996. Importance of the Ser-132 phosphorylation site in cell transformation and apoptosis induced by the adenovirus type 5 E1A protein. J. Virol. 70:5373-5383.
67. Wu, J., P. Dent, T. Jelinek, A. Woltman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069.
68. Yee, S.-P., D. T. Rowe, M. L. Tremblay, M. McDermott, and P. E. Branton. 1983. Identification of human adenovirus early region 1 products using antisera against synthetic peptides corresponding to the predicted carboxy terminus. Virology 46:1003-1013.
69. 243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter. J. Virol. 69:7402-7409.
70. Zhou, Q., R. W. Gedrich, and D. A. Engel. 1995. Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J. Virol. 69:4323-4330.